SAN FRANCISCO, Jan 13 (Reuters) - AstraZeneca has agreed to buy Boston-based Modella AI, the companies said on Tuesday, as the drug industry increases its use of artificial intelligence to accelerate the discovery of new drugs.
The companies did not disclose financial terms. In a press release, Modella AI said its "foundation models" and AI agents would be integrated into oncology research and development to support clinical development and biomarker discovery.
"Oncology drug development is becoming more complex, more data-rich and more time-sensitive," said Gabi Raia, Modella AI's chief commercial officer, adding that joining AstraZeneca would allow it to deploy its tools in global trials and clinical settings.
AstraZeneca said that this was the first acquisition of an AI firm by a big pharmaceutical company.
In an interview at the JP Morgan Healthcare Conference, AstraZeneca Chief Financial Officer Aradhana Sarin said the acquisition would "supercharge" the company's quantitative pathology and biomarker discovery efforts by bringing more data and AI capabilities in-house.
The deal was one of a number of pacts between major drug firms and AI companies that were unveiled at the healthcare conference, including a $1 billion collaboration between Nvidia and Eli Lilly. They plan to build a new research lab using Nvidia's latest-generation AI chips.
Modella will accelerate AstraZeneca’s efforts to make pathology more quantitative - using computers to analyze biopsies for relevant proteins and correlate them with clinical data - so AstraZeneca can develop “highly targeted biomarkers and then highly targeted therapeutics,” Sarin said.
The deal is an expansion of a multi-year collaboration that the companies unveiled in July.
Sarin said that partnership served as a "test drive," adding that AstraZeneca ultimately wanted Modella's data, foundation models and AI talent in-house.
She said AI tools could be used to more rapidly select patients for drug trials, which could increase the odds of clinical success and cut related costs.
(Reporting by Maggie Fick; Editing by Thomas Derpinghaus)
LATEST POSTS
- 1
Mars orbiter sees 'butterfly' crater spread its wings on the Red Planet - 2As nations push for more ambition at climate talks, chairman says they may get it
- 36 Savvy Locks for Lofts
- 4Must-Have Cooking Machine in Your Kitchen
- 5Songbirds swap colorful plumage genes across species lines among their evolutionary neighbors
- Colorado residents face earliest water restrictions ever — a harbinger of worse to come
- Lego's $650 Pokémon set is already sold out as demand, preorders surge
- Best Internet based Course for Learning Another Dialect: Which Stage Do You Like?
- Iran begins cloud seeding to induce rain amid historic drought
- JFK's granddaughter reveals terminal cancer diagnosis, criticizes cousin RFK Jr.
- What happened to Eleven after the ambiguous 'Stranger Things' series finale? Millie Bobby Brown knows — but 'swore herself to secrecy'
- Israel's Druze use AI to present to UN testimonies of 'sexual terrorism' against Syrian Druze women
- Dental, Vision, and Hearing Inclusion in Senior Protection.
- Hot peppers sent him to the ER. Two years later, a ‘ghost bill’ arrived.
